Are Platinum Drugs Ineffective for Triple-Negative Breast Cancer With Residual Invasive Disease After Neoadjuvant Chemotherapy? Reply

被引:0
|
作者
Mayer, Ingrid A. [1 ]
Zhao, Fengmin [2 ]
Arteaga, Carlos L. [3 ]
Symmans, William F. [4 ]
Park, Ben H. [1 ]
Burnette, Brian L. [5 ]
Tevaarwerk, Amye J. [6 ]
Garcia, Sofia F. [7 ]
Smith, Karen L. [8 ]
Makower, Della F. [9 ]
Block, Margaret [10 ]
Morley, Kimberly A. [11 ]
Jani, Chirag R. [12 ]
Mescher, Craig [13 ]
Dewani, Shabana J. [14 ]
Tawfik, Bernard [15 ]
Flaum, Lisa E. [7 ]
Mayer, Erica L. [16 ]
Sikov, William M. [17 ]
Rodler, Eve T. [18 ]
Wagner, Lynne I. [19 ]
DeMichele, Angela M. [20 ]
Sparano, Joseph A. [9 ]
Wolff, Antonio C. [8 ]
Miller, Kathy D. [21 ]
机构
[1] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[2] Dana Farber Canc Inst, ECOG ACRIN Biostat Ctr, Boston, MA 02115 USA
[3] UT Southwestern Simmons Canc Ctr, Dallas, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Canc Res Wisconsin & Northern Michigan CROWN NCOR, Green Bay, WI USA
[6] Univ Wisconsin Carbone Canc Ctr, Madison, WI USA
[7] Northwestern Univ, Evanston, IL USA
[8] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD USA
[9] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[10] Alegent Hlth Bergan Mercy Med Ctr, Omaha, NE USA
[11] St Joseph Mercy Hosp, Ann Arbor, MI 48104 USA
[12] Phoebe Putney Mem Hosp, Albany, GA USA
[13] Metro Minnesota Community Oncol Res Consortium, St Louis Pk, MN USA
[14] Columbus Oncol & Hematol Associates Inc, Columbus, OH USA
[15] Univ New Mexico Canc Ctr, Albuquerque, NM USA
[16] Dana Farber Canc Inst, Boston, MA 02115 USA
[17] Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA
[18] Univ Calif Davis, Davis, CA 95616 USA
[19] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[20] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[21] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46204 USA
基金
美国国家卫生研究院;
关键词
CAPECITABINE;
D O I
10.1200/JCO.21.01905
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3522 / +
页数:3
相关论文
共 50 条
  • [21] Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
    Luen, S. J.
    Salgado, R.
    Dieci, M. V.
    Vingiani, A.
    Curigliano, G.
    Gould, R. E.
    Castaneda, C.
    D'Alfonso, T.
    Sanchez, J.
    Cheng, E.
    Andreopoulou, E.
    Castillo, M.
    Adams, S.
    Demaria, S.
    Symmans, W. F.
    Michiels, S.
    Loi, S.
    ANNALS OF ONCOLOGY, 2019, 30 (02) : 236 - 242
  • [22] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [23] A novel patient-derived organoid model for triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy for screening personalized drugs.
    Liu, Feiyang
    Ma, Dandan
    Liu, Qingsong
    Qi, Xiaowei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [25] Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer: a new standard of care?
    Curigliano, Giuseppe
    LANCET ONCOLOGY, 2018, 19 (04): : 434 - 436
  • [26] Platinum-based chemotherapy in triple-negative breast cancer
    Sirohi, B.
    Arnedos, M.
    Popat, S.
    Ashley, S.
    Nerurkar, A.
    Walsh, G.
    Johnston, S.
    Smith, I. E.
    ANNALS OF ONCOLOGY, 2008, 19 (11) : 1847 - 1852
  • [27] Platinum-Based Chemotherapy in Triple-Negative Breast Cancer
    Villarreal-Garza, C.
    Bouganim, N.
    Khalaf, D.
    Clemons, M.
    Kassam, F.
    Enright, K.
    Verma, S.
    Myers, J.
    Dent, R.
    CANCER RESEARCH, 2011, 71
  • [28] Platinum-based chemotherapy in triple-negative breast cancer
    Villarreal-Garza, C. M.
    Clemons, M.
    Kassam, F.
    Enright, K.
    Verma, S.
    Myers, J. A.
    Dent, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] A meta-analysis of platinum-based neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy for triple-negative breast cancer
    Wang, Dong
    Feng, Jiafu
    Xu, Bei
    FUTURE ONCOLOGY, 2019, 15 (23) : 2779 - 2790
  • [30] Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
    Parsons, H. A.
    Blewett, T.
    Chu, X.
    Sridhar, S.
    Santos, K.
    Xiong, K.
    Abramson, V. G.
    Patel, A.
    Cheng, J.
    Brufsky, A.
    Rhoades, J.
    Force, J.
    Liu, R.
    Traina, T. A.
    Carey, L. A.
    Rimawi, M. F.
    Miller, K. D.
    Stearns, V.
    Specht, J.
    Falkson, C.
    Burstein, H. J.
    Wolff, A. C.
    Winer, E. P.
    Tayob, N.
    Krop, I. E.
    Markrigiorgos, G. M.
    Golub, T. R.
    Mayer, E. L.
    Adalsteinsson, V. A.
    ANNALS OF ONCOLOGY, 2023, 34 (10) : 899 - 906